This report summarized and analyzed the clinical data of 3 patients with food-borne botulism admitted to our department. One case was sporadic, while the other two involved family members living together. All patients initially presented with blurred vision, ptosis, and dysphagia, and the disease progressed rapidly. During the course of the disease, all three cases developed respiratory failure; one patient received non-invasive ventilatory support, whereas the other two required invasive ventilator assisted ventilation. The serum toxin tests of the 3 patients were all positive for botulinum toxin type A. Sporadic food-borne botulism shares similar early symptoms and signs to myasthenia gravis and Guillain-Barre syndrome, and requires careful differential diagnosis. Botulinum antitoxin serum is the only effective treatment, and empirical antitoxin administration can be initiated immediately upon suspicion of botulism. Early detection and timely specific treatment are critical for improving patient outcomes.

This report summarized and analyzed the clinical data of 3 patients with food-borne botulism admitted to our department. One case was sporadic, while the other two involved family members living together. All patients initially presented with blurred vision, ptosis, and dysphagia, and the disease progressed rapidly. During the course of the disease, all three cases developed respiratory failure; one patient received non-invasive ventilatory support, whereas the other two required invasive ventilator assisted ventilation. The serum toxin tests of the 3 patients were all positive for botulinum toxin type A. Sporadic food-borne botulism shares similar early symptoms and signs to myasthenia gravis and Guillain-Barre syndrome, and requires careful differential diagnosis. Botulinum antitoxin serum is the only effective treatment, and empirical antitoxin administration can be initiated immediately upon suspicion of botulism. Early detection and timely specific treatment are critical for improving patient outcomes.

Objective To investigate the changes of learning and memory function ,vascular endothelial growth factor (VEGF) and heme oxygenase‐1(HO‐1) expression in cerebral cortex and hippocampus of chronic ischemic vascular dementia rats . Methods Thirty‐six healthy SD rats were divided into the control group ,sham operation group and model group ,12 cases in each group .The chronic ischemic vascular dementia rat model was established by the permanent bilateral carotid artery occlusion The sham operation group received the same treatment to the model group except without bilateral carotid artery occlusion .The learning and memory abilities were tested by the Morris water maze experiment and climbing rope strength experiment at 1 ,4 ,8 ,12 weeks respectively .The expressions of VEGF and HO‐1 in rat cerebral cortex and hippocampus was determined by immunohistochemical SP technique .Results The escape latency time at 8 ,12 weeks in the model group was longer than that in the sham operation group and control group ,and the number of crossing the platform was less than that in the sham operation group and control group ,the differences were statistically significant (P<0 .05);the time of climbing at 1 -12 weeks had no statistical difference between the model group and the sham operation group and between the model group and the control group (P>0 .05) .The positive expression of HO‐1 and VEGF protein contents in the control group and sham operation group was less than that in the model group with sta‐tistical difference(P<0 .05) .Conclusion Chronic cerebral hypoperfusion has a permanent damage to the learning and memory abil‐ities in rats ,while has no influence on the motor function .VEGF and HO‐1 may play a protective role in chronic cerebral ischemia .

To study the chemical constituents from the bark of Myrica rubra, fourteen compounds were isolated from the methanolic extract using various chromatographic techniques, including silica gel, Sephadex LH-20 and preparative HPLC. Their structures were identified on the basis of chemical properties and spectroscopic data, as 3, 5-dimethoxy-4-hydroxymyricanol (1), myricanol (2), myricanone (3), myricanol 11-sulfate (4), myricitrin (5), quercetin (6), quercetin-3-rhamnoside (7), tamarixol (8), uvaol (9), ursolic acid (10), taraxerol (11), myricadiol (12), β-sitosterol (13) and β-daucosterol (14). Among them, compound 1 is a new compound, named as 3, 5-dimethoxy-4-hydroxymyricanol, compounds 8, 9 were isolated from the genus Myrica for the first time.